Sign in
Taking peopleNo phase

Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment: a French Prospective Register

Key facts

Who runs it
Rennes University Hospital
Where
France26 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
11 Oct 2024
Expected to end
11 Jan 2028
Type of study
Observational
Treatments tested
  • Whole exome sequencing to detect myocardial genetic mutations (SCA group only)
Record updated
25 August 2026

Who can take part

Age
12 years to 35 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Victims of SCA:; Aged between 12 and 35 years; No known cardiovascular pathology; Experienced a sudden and non-traumatic SCA during or within one hour of participating in sports activities (leisure, training, or competition); For resuscitated victims (SCA group): A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, organs, or authorities responsible for assisting or representing them if they are unable to express their wishes); For non-resuscitated victims (SCD group): A person who has not formally objected to the reuse of their medical data during their lifetime
  • First-Degree Relatives:; A person or legal representative who does not oppose participation in the research after being informed about the study (including individuals, bodies, or authorities responsible for assisting or representing them if they are unable to express their wishes); Non-Inclusion Criteria:
  • For resuscitated SCA cases, individuals weighing less than 20 kg
  • Victims or legal representatives who are subject to legal protection or deprived of their liberty

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 35 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The increased risk of sudden cardiac arrest (SCA) or sudden cardiac death (SCD) related to vigorous physical activity is well-documented. Currently, for young victims (under 35 years) of SCA/SCD, no etiology is found in 40 to 50% of cases after a standard medical assessment, leading to two important consequences. For the victim's family, it is difficult to understand and accept this tragic event, and the risk of it occurring in another family member is a source of concern. Medically, the absence of a known cause limits the ability to effectively prevent such events.

Read full original descriptionShow less

The RESOUDRE study will be a national, prospective, observational registry of young victims (12-35 years) of sports-related SCA/SCD. All cases will undergo the recommended etiological assessment, including autopsy for SCA cases, along with whole exome genetic analysis and toxicological testing. In the event a genetic pathology is identified, a genetic evaluation will be offered to other family members, and appropriate medical care will be provided if necessary. The results of this study could significantly reduce the number of unexplained sport-related SCA/SCD cases and aid in preventing these incidents among affected families.

The group in the trial

  • Victims of sport-related sudden cardiac arrest (SCA) : resuscitated SCA and non-resuscitated SCA

    Following a sport-related sudden cardiac arrest (SCA), resuscitation attempts are frequently made due to the high likelihood of witnesses at the scene. These resuscitation efforts are successful in more than 40% of cases. The study population will therefore be divided into two groups: a group of resuscitated SCA victims (SCA group) and a group of non-resuscitated or unsuccessfully resuscitated victims (SCD group). The RESOUDRE study is an observational study focusing on individuals who have experienced SCA. Depending on the outcome-whether the individual survives or not-the etiological assessment will differ. While the study design refers to two distinct groups for clarity, they represent a single population, and no statistical comparison between the two groups will be made.

    Treatment: Whole exome sequencing to detect myocardial genetic mutations (SCA group only)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Registre Prospectif français Des Morts Subites Chez Des Sportifs Jeunes
Criteria questions
Built from NCT06642168, who can take part
Record updated
25 August 2026